iRhythm Holdings, Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
iRhythm Holdings, Inc. (IRTC) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $64.00 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2022-08-05
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2022-06-30 was $36.00M, a 50.00% increase year-over-year.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2022-03-31 was $28.00M, a 81.49% decline year-over-year.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2021-12-31 was $33.00M, a 30.53% decline year-over-year.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2021-09-30 was $47.22M, a 490.19% increase year-over-year.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2021 was $255.51M, a 77.26% increase from fiscal 2020.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2020 was $144.15M, a 50.78% increase from fiscal 2019.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2019 was $95.60M, a 24.42% decline from fiscal 2018.
- iRhythm Holdings, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2018 was $126.49M, a 28.15% increase from fiscal 2017.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2022-06-30 | $36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $64.00M 10-Q · filed 2022-08-05 | $97.00M derived: sum of 3 quarters · filed 2022-08-05 | $144.22M derived: sum of 4 quarters · filed 2022-08-05 |
| 2022-03-31 | $28.00M 10-Q · filed 2022-05-06 | $61.00M derived: sum of 2 quarters · filed 2022-05-06 | $108.22M derived: sum of 3 quarters · filed 2022-05-06 | $132.22M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $80.22M derived: sum of 2 quarters · filed 2022-02-28 | $104.22M derived: sum of 3 quarters · filed 2022-08-05 | $255.51M 10-K · filed 2022-02-28 |
| 2021-09-30 | $47.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $71.22M derived: sum of 2 quarters · filed 2022-08-05 | $222.51M 10-Q · filed 2021-11-05 | $270.01M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-06-30 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $175.30M 10-Q · filed 2022-08-05 | $222.80M derived: sum of 3 quarters · filed 2022-08-05 | $230.80M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $151.30M 10-Q · filed 2022-05-06 | $198.80M derived: sum of 2 quarters · filed 2022-05-06 | $206.80M derived: sum of 3 quarters · filed 2022-05-06 | $238.65M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $47.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $55.50M derived: sum of 2 quarters · filed 2022-02-28 | $87.34M derived: sum of 3 quarters · filed 2022-02-28 | $144.15M 10-K · filed 2022-02-28 |
| 2020-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $39.84M derived: sum of 2 quarters · filed 2021-11-05 | $96.64M 10-Q · filed 2021-11-05 | $114.34M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $31.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $88.64M 10-Q · filed 2021-08-09 | $106.34M derived: sum of 3 quarters · filed 2022-02-28 | $123.69M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $56.80M 10-Q · filed 2021-05-10 | $74.50M derived: sum of 2 quarters · filed 2022-02-28 | $91.85M derived: sum of 3 quarters · filed 2022-02-28 | $114.70M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $35.05M derived: sum of 2 quarters · filed 2022-02-28 | $57.90M derived: sum of 3 quarters · filed 2022-02-28 | $95.60M 10-K · filed 2022-02-28 |
| 2019-09-30 | $17.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $40.20M derived: sum of 2 quarters · filed 2020-11-06 | $77.90M 10-Q · filed 2020-11-06 | $96.79M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $22.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $60.55M 10-Q · filed 2020-08-07 | $79.44M derived: sum of 3 quarters · filed 2021-02-26 | $114.04M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $37.70M 10-Q · filed 2020-05-08 | $56.59M derived: sum of 2 quarters · filed 2021-02-26 | $91.19M derived: sum of 3 quarters · filed 2021-02-26 | $136.19M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $18.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $53.49M derived: sum of 2 quarters · filed 2021-02-26 | $98.49M derived: sum of 3 quarters · filed 2021-02-26 | $126.49M 10-K · filed 2021-02-26 |
| 2018-09-30 | $34.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-12-23 | $79.60M derived: sum of 2 quarters · filed 2019-12-23 | $107.61M 10-Q · filed 2019-12-23 | $137.63M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $45.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $73.00M 10-Q · filed 2019-08-06 | $103.03M derived: sum of 3 quarters · filed 2020-03-02 | $143.91M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $28.00M 10-Q · filed 2019-05-10 | $58.03M derived: sum of 2 quarters · filed 2020-03-02 | $98.91M derived: sum of 3 quarters · filed 2020-03-02 | $123.41M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $30.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $70.91M derived: sum of 2 quarters · filed 2020-03-02 | $95.41M derived: sum of 3 quarters · filed 2020-03-02 | $98.71M 10-K · filed 2020-03-02 |
| 2017-09-30 | $40.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $65.38M derived: sum of 2 quarters · filed 2018-10-30 | $68.68M 10-Q · filed 2018-10-30 | |
| 2017-06-30 | $24.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $27.80M 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | $3.30M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |